Donation

Videos
Dr. Paul Richardson on Myeloma Highlights from ASCO 2018In this video, Dr. Paul Richardson (Dana Farber Cancer Institute, Boston) talks about the most exciting multiple myeloma clinical trials presented at ASCO 2018.He comments on the…
June 04, 2018
Videos
Dr. Philippe Moreau Discusses Myeloma Abstracts from ASCO 2018 (in French)Dr. Philippe Moreau (University Hospital Hotel Dieu — Nantes, France) talks about the ongoing clinical trials in multiple myeloma, frontline therapies for young and elderly patients, and the future of CAR-T…
June 04, 2018
Videos
Dr. Luciano Costa Gives an Overview of ASCO 2018In this video, Dr. Luciano Costa (University of Alabama, Birmingham, Alabama) provides his overview of multiple myeloma research that was presented at ASCO 2018. He discusses the following studies:The…
June 04, 2018
Videos
Dr. Ajay Chari Discusses a Phase 3 Daratumumab Combination Therapy Study from ASCO 2018In this video, Dr. Ajai Chari (Icahn School of Medicine, Mt. Sinai Hospital - New York) discusses an update of aphase III study…
June 04, 2018
Videos
Dr. Joseph Mikhael on ASCO 2018 Abstracts Addressing Monoclonal Antibodies in Myeloma Dr. Joseph Mikhael, Chief Medical Officer at the International Myeloma Foundation, highlights an ASCO 2018 session about monoclonal antibodies used to treat multiple myeloma. Dr. Mikhael…
June 04, 2018
Page
The International Myeloma Working Group Summit is held annually each June, between two of the year’s largest cancer conferences, the American Society of Clinical Oncology (ASCO) in Chicago and the European Hematology Association (EHA).Report from the 2018 Summit of the…
September 04, 2018
Videos
Dr. S. Vincent Rajkumar Discusses Top Myeloma Trials from ASCO 2018Dr. S. Vincent Rajkumar (Mayo Clinic, Rochester, MN) discusses which five trials he found to be most significant at ASCO 2018:Using…
June 04, 2018

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.